Literature DB >> 18548559

Influence of ocular filtering in EEG data on the assessment of drug-induced effects on the brain.

Sergio Romero1, Miguel A Mañanas, Manel J Barbanoj.   

Abstract

Ocular artifacts in EEG signals affect the interpretation of clinical study results. The aim of this study was to assess the influence of automatic ocular filtering procedures in the conclusions drawn from a pharmaco-EEG trial. Regression analysis, gold standard, and blind source separation (BSS), Second Order Blind Identification algorithm, ocular filtering procedures were compared using time, frequency, topographic and tomographic brain mapping approaches and pharmacokinetic-pharmacodynamic (PK-PD) relationships. Data consisted of EEGs obtained from 20 volunteers who received single oral doses of haloperidol 3 mg, risperidone 1 mg, olanzapine 5 mg and placebo in a randomized cross-over double-blind design. Although the BSS-based technique preserved brain activity more than regression analysis in anterior leads, in general, topographic significance probability maps globally showed similar results with both methods for most spectral variables. However, different results were obtained when using whole multi-channel information for studying drug effects in the brain: (i) higher correlations between PK and PD time courses showing that BSS allowed estimation of spectral variables more accurately related to drug effects and (ii) larger and more symmetric drug related tomographic LORETA maps showing that BSS led to results that were more neurophysiopharmacologically sound. Definitely, the BSS-based procedure is an effective and efficient preprocessing method to remove ocular artifacts from EEG data. The selection of the ocular filtering procedure could determine different results whose impact depends on the evaluating tool applied to analyze the pharmaco-EEG data. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18548559      PMCID: PMC6870813          DOI: 10.1002/hbm.20614

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  23 in total

1.  Removal of eye activity artifacts from visual event-related potentials in normal and clinical subjects.

Authors:  T P Jung; S Makeig; M Westerfield; J Townsend; E Courchesne; T J Sejnowski
Journal:  Clin Neurophysiol       Date:  2000-10       Impact factor: 3.708

2.  Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.

Authors:  Jordi Riba; Peter Anderer; Francesc Jané; Bernd Saletu; Manel J Barbanoj
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

3.  Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology.

Authors:  P Anderer; H V Semlitsch; B Saletu; M J Barbanoj
Journal:  Psychiatry Res       Date:  1992-08       Impact factor: 3.222

4.  Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method.

Authors:  J L Lancaster; L H Rainey; J L Summerlin; C S Freitas; P T Fox; A C Evans; A W Toga; J C Mazziotta
Journal:  Hum Brain Mapp       Date:  1997       Impact factor: 5.038

5.  Automatic correction of artifact from single-trial event-related potentials by blind source separation using second order statistics only.

Authors:  K H Ting; P C W Fung; C Q Chang; F H Y Chan
Journal:  Med Eng Phys       Date:  2006-01-06       Impact factor: 2.242

6.  Extraction of ocular artefacts from EEG using independent component analysis.

Authors:  R N Vigário
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-09

Review 7.  EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs.

Authors:  Bernd Saletu; Peter Anderer; Gerda M Saletu-Zyhlarz
Journal:  Clin EEG Neurosci       Date:  2006-04       Impact factor: 1.843

8.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers.

Authors:  U Ebert; M Grossmann; R Oertel; T Gramatté; W Kirch
Journal:  J Clin Pharmacol       Date:  2001-01       Impact factor: 3.126

Review 9.  Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology.

Authors:  M Valle; M J Barbanoj; F Jané
Journal:  Methods Find Exp Clin Pharmacol       Date:  2002

10.  Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging).

Authors:  B Saletu; P Anderer; K Kinsperger; J Grünberger
Journal:  Methods Find Exp Clin Pharmacol       Date:  1987-06
View more
  3 in total

1.  Evaluation of multiple comparison correction procedures in drug assessment studies using LORETA maps.

Authors:  Joan Francesc Alonso; Sergio Romero; Miguel Ángel Mañanas; Mónica Rojas; Jordi Riba; Manel José Barbanoj
Journal:  Med Biol Eng Comput       Date:  2015-06-04       Impact factor: 2.602

Review 2.  Electroencephalogram-based pharmacodynamic measures: a review.

Authors:  Michael Bewernitz; Hartmut Derendorf
Journal:  Int J Clin Pharmacol Ther       Date:  2012-03       Impact factor: 1.366

3.  Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics.

Authors:  Takashi Ozaki; Atsuhito Toyomaki; Naoki Hashimoto; Ichiro Kusumi
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.